Pharmaceutical License Agreement Template for the United Arab Emirates
Generate a bespoke document
What is a Pharmaceutical License Agreement?
The Pharmaceutical License Agreement is a crucial document used in the UAE pharmaceutical industry when one party (licensor) grants another party (licensee) the rights to manufacture, distribute, or sell pharmaceutical products within the UAE territory. This agreement type is essential for international pharmaceutical companies entering the UAE market or local companies acquiring rights to produce or distribute pharmaceutical products. The document must comply with UAE Federal Law No. 8 of 2019 and various other healthcare regulations, while addressing key commercial aspects such as intellectual property rights, quality control, regulatory compliance, and financial terms. The agreement is particularly important given the UAE's position as a regional healthcare hub and its strict regulatory framework for pharmaceutical products. It typically includes detailed provisions for MOHAP approval processes, quality standards, and specific emirate-level requirements.
About the Pharmaceutical License Agreement
A Pharmaceutical License Agreement is a specialized legal contract that allows you to grant or acquire rights to manufacture, distribute, or sell pharmaceutical products in the United Arab Emirates. This agreement serves as the foundation for pharmaceutical partnerships and market entry strategies while ensuring compliance with UAE's comprehensive healthcare regulatory framework.
When do you need this document?
You need a Pharmaceutical License Agreement when entering into any arrangement involving pharmaceutical products in the UAE. This includes situations where an international pharmaceutical company wants to license its products to a local UAE manufacturer, when a biotechnology company grants distribution rights to a healthcare product distributor, or when research institutions transfer pharmaceutical technology to commercial entities. The agreement is also essential when contract manufacturing organizations (CMOs) provide manufacturing services for pharmaceutical products, or when companies establish joint ventures for pharmaceutical development and commercialization in the UAE market.
Key legal considerations
Your agreement must address several critical legal aspects to ensure enforceability and compliance. Intellectual property protection is paramount, requiring clear definitions of patents, trademarks, and trade secrets being licensed, along with territorial restrictions and exclusivity terms. Quality control provisions must specify manufacturing standards, testing requirements, and compliance with Good Manufacturing Practices (GMP). Regulatory compliance clauses should outline responsibilities for obtaining necessary approvals from MOHAP, Dubai Health Authority (DHA), or Department of Health Abu Dhabi (DOH). Financial terms including royalty rates, milestone payments, and minimum purchase commitments need careful structuring. The agreement should also include termination provisions, dispute resolution mechanisms, and liability limitations to protect both parties' interests.
Legal requirements in United Arab Emirates
Under UAE Federal Law No. 8 of 2019 on Medical Products, Pharmacy Profession and Pharmaceutical Establishments, your agreement must ensure that all pharmaceutical activities comply with national regulatory standards. The licensed products must be registered with MOHAP and meet UAE pharmacopoeia requirements. Manufacturing facilities must obtain proper licenses and undergo regular inspections by health authorities. Your agreement should reference compliance with UAE Federal Law No. 17 of 2002 (Patent Law) for patent protection and Federal Law No. 37 of 1992 (Trademark Law) for brand protection. Additionally, the agreement must consider emirate-specific regulations, as Dubai and Abu Dhabi have additional health authority requirements. Import and export provisions must comply with UAE customs regulations, and any technology transfer must align with UAE's economic diversification objectives while respecting international pharmaceutical standards.
GOVERNING LAW
Applicable law
This Pharmaceutical License Agreement is drafted to comply with United Arab Emirates law. Key legislation includes:
UAE Federal Law No. 37 of 1992 (Trademark Law): Governs trademark protection and registration, crucial for pharmaceutical branding and product protection in license agreements.
UAE Federal Law No. 7 of 2002 (Copyright Law): Protects intellectual property rights related to pharmaceutical documentation, research, and related materials.
UAE Federal Law No. 17 of 2002 (Patent Law): Crucial for protecting pharmaceutical patents and innovations, including manufacturing processes and formulations.
Cabinet Resolution No. 4 of 2020: Regulations concerning medical products and pharmaceutical facilities, including detailed implementation guidelines for Federal Law No. 8 of 2019.
Federal Law No. 18 of 1993 (Commercial Transactions Law): Governs commercial transactions and contracts, providing the general framework for licensing agreements.
UAE Federal Law No. 4 of 2012 (Competition Law): Regulates anti-competitive practices and must be considered in exclusive licensing arrangements.
MOHAP Resolution No. 321 of 2009: Specific regulations on pharmaceutical establishments, including licensing requirements and operational standards.
GCC Common Customs Law: Relevant for import/export provisions in pharmaceutical licensing agreements within the GCC region.
Explore 208,390+ legal templates
Explore 208,390+ legal templates
Genie's Security Promise
Genie is the safest place to draft. Here's how we prioritise your privacy and security.
Your data is private:
We do not train on your data; Genie's AI improves independently
All data stored on Genie is private to your organisation
Your documents are protected:
Your documents are protected by ultra-secure 256-bit encryption
We are ISO27001 certified, so your data is secure
Organizational security:
You retain IP ownership of your documents and their information
You have full control over your data and who gets to see it